000 02239cam a2200349 a 4500
003 EG-GiCUC
005 20250223031206.0
008 150331s2014 ua d f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.11.33.Ph.D.2014.Ba.H
100 0 _aBasem Elsayed Eysa Elsayed
245 1 0 _aHistopathological findings in liver biopsy in relation to virological response in chronic hepatitis C patients Receiving combined therapy /
_cBasem Elsayed Eysa Elsayed ; Supervised Gamal Eldin Esmat , Wahid Halim Doss , Ehsan Hassan Hassan
246 1 5 _aالتغيرات المرضية في العينات الكبدية ومدي تأثيرھا علي الاستجابة للعلاج المزدوج للمرضي المصابين بفيروس (س) المزمن
260 _aCairo :
_bBasem Elsayed Eysa Elsayed ,
_c2014
300 _a103 P. :
_bcharts ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
520 _aIn conclusion, considering the value and safety of LB, and the current limitations of noninvasive tests, LB will continue to remain, in the nearby future, as the cornerstone and the gold standard test in the assessment of liver fibrosis and histology. Accordingly, treatment decision in less developed countries should be tailored to attain the highest cost effective disease outcome. While great efforts and advances have been made to improve noninvasive markers, nevertheless, major steps remain ahead before these tests can replace LB in both the information obtained and the accuracy in diagnosis. The relapse of patients could be predicted pretreatment by good patient selection, as well as patient sustained virological response
530 _aIssued also as CD
653 4 _aAssessment of liver tissue
653 4 _aChronic hepatitis C
653 4 _aHepatitis C Overview
700 0 _aEhsan Hassan Hassan ,
_eSupervisor
700 0 _aGamal Eldin Esmat ,
_eSupervisor
700 0 _aWahid Halim Doss ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aAml
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c50180
_d50180